Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: a double-blinded, randomised clinical trial
ISRCTN ISRCTN71482124
ClinicalTrials.gov identifier
Public title Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: a double-blinded, randomised clinical trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Null: There is no difference in residual ulcer size whether a corneal ulcer patient was treated with antibiotic alone or antibiotic with steroid.

Alternative: There is a significant difference in residual ulcers size between corneal ulcer patients treated with antibiotic alone and with antibiotic with steroid.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Corneal ulcers
Participants - inclusion criteria 1. Bacterial corneal ulcer, defined as corneal epithelial defect and stromal inflammation of presumed bacterial origin,that is culture confirmed or gram stain positive
2. Involvement of only one eye
3. Over the age of 12 years
Participants - exclusion criteria 1. Fungal, viral or amoebic keratitis
2. Known sensitivity or allergy to trial drugs
3. Perforated ulcer
4. Involvement of only functional eye, best corrected visual acuity worse than 20/200 in the uninfected eye
5. Use of topical or systemic steroids concurrently or within the past 2 months
Anticipated start date 15/09/2005
Anticipated end date 14/09/2007
Status of trial Completed
Patient information material
Target number of participants 122
Interventions Antibiotic-only or Antibiotic-steroid combination treatment
Primary outcome measure(s) Residual ulcer size compared to baseline
Secondary outcome measure(s) 1. Time to healing (days)
2. Rate of cure or treatment failure
3. Visual acuity
4. Quality of life
5. Physician Scoring of Ocular symptoms and signs
Sources of funding Physicians' Services Inc (Canada)
Trial website
Publications
Contact name Dr  William  Hodge
  Address Ottawa Hospital - General Campus
The University of Ottawa Eye Institute
501 Smyth Road
  City/town Ottawa, Ontario
  Zip/Postcode K1H 8L6
  Country Canada
  Tel +1 613 737 8218
  Fax +1 613 739 6139
  Email whodge@ottawahospital.on.ca
Sponsor Physicians' Services Incorporated Foundation (Canada)
  Address 1006-5160 Yonge Street
  City/town North York, Ontario
  Zip/Postcode M2N 6L9
  Country Canada
  Tel +1 416 226 6323
  Fax +1 416 226 6080
  Email psif@psifoundation.org
Date applied 24/08/2005
Last edited 15/09/2009
Date ISRCTN assigned 21/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central